IKNA - Ikena Oncology - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

IKNA is currently covered by 5 analysts with an average price target of $12.72. This is a potential upside of $11.43 (886.05%) from yesterday's end of day stock price of $1.29.

Ikena Oncology's activity chart (see below) currently has 5 price targets and 13 ratings on display. The stock rating distribution of IKNA is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for IKNA is $13, Lowest price target is $13, average price target is $12.72.

Most recent stock forecast was given by JUDAH FROMMER from CREDIT SUISSE on 16-May-2023. First documented stock forecast 13-Aug-2021.

Best performing analysts who are covering IKNA - Ikena Oncology:

Robert Burns Judah Frommer Evan Seigerman

Currently out of the existing stock ratings of IKNA, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

13

$11.7 (900.00%)

13

11 months 8 days ago

0/2 (0%)

$6.84 (111.04%)

Buy

13

$11.7 (900.00%)

27

1 years 1 months 9 days ago

0/2 (0%)

$8.75 (205.88%)

Buy

26

1 years 4 months 26 days ago

0/2 (0%)

$18.7 (256.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IKNA (Ikena Oncology) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on IKNA (Ikena Oncology) with a proven track record?

ROBERT BURNS

Which analyst has the current lower performing score on IKNA (Ikena Oncology) with a proven track record?

EVAN SEIGERMAN

Which analyst has the most public recommendations on IKNA (Ikena Oncology)?

Robert Burns has 1 price targets and 4 ratings on IKNA

Which analyst is the currently most bullish on IKNA (Ikena Oncology)?

Evan Seigerman with highest potential upside - $11.7

Which analyst is the currently most reserved on IKNA (Ikena Oncology)?

Robert Burns with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?